
Helius Medical Technologies Inc Investor Relations Material
Latest events

Status Update
Helius Medical Technologies Inc

Q1 2025
1 May, 2025

Q4 2024
24 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Helius Medical Technologies Inc
Access all reports
Helius Medical Technologies Inc. is a neurotechnology company focused on developing non-invasive treatments for neurological conditions. The company’s primary product, the Portable Neuromodulation Stimulator (PoNS), is designed to help improve balance and gait in patients with neurological diseases or trauma, such as multiple sclerosis and traumatic brain injury. The PoNS® device stimulates the brain through the tongue, promoting neuroplasticity and aiding in physical rehabilitation. Helius Medical Technologies aims to offer innovative therapeutic solutions to enhance the quality of life for individuals with neurological impairments. The company is headquartered in Newtown, Pennsylvania, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
HSDT
Country
🇺🇸 United States